Omega Funds — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Nuvation Bionuvationbio.cominNYSE: NUVBOct 2020SEC filinghigh confidence
Nuvation Bio is a global oncology company developing and commercializing novel therapies for difficult-to-treat cancers, targeting indications where conventional treatments have failed.
BiotechHealthtechNew York, US
David Hung(Founder, President & Chief Executive Officer)
Board seatMichelle DoigClaudio Nessi· per SEC Form D · $275.3M raise · filed Oct 2020
Co-investorsAisling CapitalDecheng CapitalEcoR1 CapitalVertex Ventures China
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.